Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update

Rheumatoid arthritis (RA) is an autoimmune disease with destructive arthritis as its main clinical manifestation, which is a major cause of disability. It is very important to formulate and update a guideline for the diagnosis and treatment of RA that adhere to international guideline development standards and can be applied to clinical practice in China. This guideline is endorsed and developed by the National Clinical Research Center for Dermatologic and Immunologic Diseases, collaborated with Rheumatologists Branch of Chinese Medical Doctor Association, Rheumatology Rehabilitation Branch of Chinese Association of Rehabilitation Medicine, Rheumatology Branch of Chinese Research Hospital Association, and Rheumatology Branch of Beijing Association of Holistic Integrative Medicine, based on grading of recommendations assessment, development and evaluation (GRADE) and reporting items for practice guidelines in healthcare (RIGHT). Evidence-based recommendation were developed for 10 clinical scenario that are most relevant to Chinese rheumatologists, aiming to improve and standardize the diagnosis and treatment of RA in China, which may finally improve the quality of life and prognosis of patients.

Authors

Institutions

Publication Details

Journal
Rheumatology and Immunology Research
Published
2024-12-01
DOI
https://doi.org/10.1515/rir-2024-0028
Citations
8
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
3.76

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update

Shengqian Xu, Pingting Yang, Lie Dai, Yameng Sun et al.
8 citations
Rheumatology and Immunology Research
Rheumatoid Arthritis Research and Therapies
3.76
article

Chinese guidelines for the diagnosis and treatment of rheumatoid arthritis: 2024 update

Shengqian Xu, Pingting Yang, Lie Dai, Yameng Sun, Jin Lin, Huji Xu, Zhaohui Zheng, Shengyun Liu, Lijun Wu, Zongwen Shuai, Xinping Tian, Dongbao Zhao, Cibo Huang, Mengtao Li, Nan Jiang, Yi Liu, Jian Xu, Qian Wang, Hongbing Li, Fen Li, Zhenyu Jiang, Caifeng Li, Yan Zhao, Yaolong Chen, Miaojia Zhang, Xiaofeng Zeng, Liangjing Lu
article en
8 citations

Abstract

Rheumatoid arthritis (RA) is an autoimmune disease with destructive arthritis as its main clinical manifestation, which is a major cause of disability. It is very important to formulate and update a guideline for the diagnosis and treatment of RA that adhere to international guideline development standards and can be applied to clinical practice in China. This guideline is endorsed and developed by the National Clinical Research Center for Dermatologic and Immunologic Diseases, collaborated with Rheumatologists Branch of Chinese Medical Doctor Association, Rheumatology Rehabilitation Branch of Chinese Association of Rehabilitation Medicine, Rheumatology Branch of Chinese Research Hospital Association, and Rheumatology Branch of Beijing Association of Holistic Integrative Medicine, based on grading of recommendations assessment, development and evaluation (GRADE) and reporting items for practice guidelines in healthcare (RIGHT). Evidence-based recommendation were developed for 10 clinical scenario that are most relevant to Chinese rheumatologists, aiming to improve and standardize the diagnosis and treatment of RA in China, which may finally improve the quality of life and prognosis of patients.

Rheumatology and Immunology ResearchVol. 5(4)
Central South University (CN), Sun Yat-sen University (CN), Second Military Medical University (CN), Shenzhen University (CN), Shanghai Jiao Tong University (CN), Capital Medical University (CN), Jilin University (CN), Anhui Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Sichuan University (CN), Kunming Medical University (CN), Renji Hospital (CN), Peking Union Medical College Hospital (CN), West China Hospital of Sichuan University (CN), Sun Yat-sen Memorial Hospital (CN), Nanjing Drum Tower Hospital (CN), Changhai Hospital (CN), First Affiliated Hospital of Kunming Medical University (CN), People's Hospital of Xinjiang Uygur Autonomous Region (CN), First Hospital of Jilin University (CN), First Affiliated Hospital of Anhui Medical University (CN), First Hospital of China Medical University (CN), Beijing Children’s Hospital (CN), Second Xiangya Hospital of Central South University (CN), First Affiliated Hospital of Zhengzhou University (CN), Xijing Hospital (CN), First Affiliated Hospital Zhejiang University (CN), Inner Mongolia Medical University (CN), Lanzhou University (CN), Nanjing Medical University (CN), China Medical University (CN), Air Force Medical University (CN)
Lanzhou University, Inner Mongolia Medical University, Sun Yat-sen University, Central South University, Anhui Medical University, Kunming Medical University, Zhejiang University, Shanghai Jiao Tong University, Chinese Academy of Medical Sciences, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Xiangya Hospital, Central South University
Partnerships for the goals
Openalex Percentile: Top 6%
Rheumatoid Arthritis Research and Therapies
3.76
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.